Promo Code – $100 off at Boston Testosterone through December 13, 2013
December 11, 2013
Boston Testosterone Partners, low t, low testosterone, testosterone replacement doctor, testosterone replacement therapy
Through December 13, 2013 only, join Boston Testosterone and receive $100 off our one-time clinic fee. Lock in the nation’s lowest cost testosterone therapy before 2014 price increases.
With over 37,000 Facebook and Google+ fans and thousands of satisfied patients, find out why Boston Testosterone is the Nation’s best Testosterone Therapy Medical Clinic for Men.
For more information, click here: http://www.bostontestosterone.com/#!get-started
**This offer is limited to the first 50 patients to join. If you do not qualify for therapy after blood testing, your clinic fee is always refunded.
Testosterone replacement therapy
Testosterone therapy has been used for more than 60 years in the treatment of male hypogonadism. The classical forms of hypogonadism are comprised of primary testicular failure or insufficient testicular stimulation due to the lack of pituitary gonadotropins. Typical causes of primary hypogonadism are Klinefelter’s syndrome, anorchia or acquired disturbances of testicular function. Secondary hypogonadism is characterized by insufficient production of pituitary gonadotropins, due either to pituitary failure or defects at the hypothalamic level. It is unequivocally accepted in clinical practice that any male with inadequately low testosterone production for his age will require androgen therapy. In addition to the classical forms of hypogonadism, the past decade of research has clearly demonstrated that, with increasing age, many men will suffer from decreasing testosterone production. About 15-25% of men over the age of 50 years will experience serum testosterone levels well below the threshold considered normal for men between 20 and 40 years of age.
Studies substituting testosterone in elderly men with low serum testosterone have shown that men with clinical symptoms identical to the symptomatology of classical hypogonadism will benefit most from such therapy. Therefore, it is the general consensus to treat men with age-related hypogonadism when clinical symptoms are present that can be potentially corrected by testosterone administration.
Testosterone injections have a very favorable pharmacokinetic profile, with one injection every couple weeks maintaining serum testosterone well within the normal range. Intramuscular testosterone cypionate is the methods of choice and very suitable for hormone therapy in men suffering from hypogonadism.